
Sign up to save your podcasts
Or


Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Scientific American4
8282 ratings
Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices

30,609 Listeners

11,099 Listeners

215 Listeners

1,729 Listeners

52 Listeners

1,381 Listeners

756 Listeners

76 Listeners

59 Listeners

442 Listeners

2,262 Listeners

383 Listeners

453 Listeners

600 Listeners

155 Listeners

44 Listeners

62,601 Listeners